(Q36352015)

13 August 2017

1 reference

title

The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure (English)

1 reference

13 August 2017

0 references

0 references

chronic heart failure

1 reference

Roy S Gardner

1

1 reference

13 August 2017

Theresa A McDonagh

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Expert Review of Cardiovascular Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

51-57

1 reference

Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Anemia and its relationship to clinical outcome in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Endothelin antagonists for chronic heart failure: do they have a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Atrial natriuretic peptides predict mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.1.51

21 January 2018

Identifiers

DOI

10.1586/14779072.4.1.51

1 reference

13 August 2017

1 reference